These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10720990)

  • 1. Neonatal urticaria due to prostaglandin E1.
    Carter EL; Garzon MC
    Pediatr Dermatol; 2000; 17(1):58-61. PubMed ID: 10720990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brown fat necrosis in the setting of congenital heart disease and prostaglandin E1 use: a case report.
    Raboi CA; Smith W
    Pediatr Radiol; 1999 Jan; 29(1):61-3. PubMed ID: 9880620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudo-Bartter syndrome in a neonate on prostaglandin infusion.
    Vanhaesebrouck S; Allegaert K; Vanhole C; Devlieger H; Gewillig M; Proesmans W
    Eur J Pediatr; 2003 Sep; 162(9):569-71. PubMed ID: 12811550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical Hyperostosis after Long-Lasting Prostaglandin E1 Treatment in a Newborn with Complex Congenital Heart Disease.
    Celona A; Giardina C; Pappalardo S; Secinaro A; Oreto L; Agati S; Romeo P
    J Pediatr; 2020 Nov; 226():302-303. PubMed ID: 32721399
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis.
    Lacher M; Schneider K; Dalla Pozza R; Schweinitz DV
    Eur J Pediatr Surg; 2007 Oct; 17(5):362-4. PubMed ID: 17968795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical hyperostosis secondary to prolonged use of prostaglandin E1.
    de Almeida JF; Kimura H; Hercowitz LH; Korkes H; Troster EJ
    Clinics (Sao Paulo); 2007 Jun; 62(3):363-6. PubMed ID: 17589681
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
    Pacher R; Stanek B; Hülsmann M; Berger R; Siegel A; Daneschvar H; Rödler S; Frey B; Grimm M; Laufer G
    Eur Heart J; 1997 Feb; 18(2):318-29. PubMed ID: 9043849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal transport issues with prostaglandin E1 infusions.
    Grubbs TC; Kraft NL
    Air Med J; 2002; 21(3):8-12. PubMed ID: 11994726
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute vascular reaction due to lipo-prostaglandin E1.
    Fujimura Y; Watanabe M; Natsuga K; Shimizu H
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e273-e274. PubMed ID: 29356126
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complications of prostaglandin E1 treatment of congenital heart disease in paediatric medical intensive care].
    Lucron H; Chipaux M; Bosser G; Le Tacon S; Lethor JP; Feillet F; Burger G; Monin P; Marçon F
    Arch Mal Coeur Vaiss; 2005 May; 98(5):524-30. PubMed ID: 15966603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkalization does not alleviate penile pain induced by intracavernous injection of prostaglandin E1.
    Godschalk M; Gheorghiu D; Katz PG; Mulligan T
    J Urol; 1996 Sep; 156(3):999-1000. PubMed ID: 8709384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantation.
    Daneschvar H; Pacher R; Rödler S; Stanek B; Hülsmann M; Grimm M; Laufer G; Wolner E; Bunzel B
    Wien Klin Wochenschr; 1996; 108(16):510-4. PubMed ID: 8840497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrichosis around a leg ulcer being treated with prostaglandin E1 ointment.
    Honda T; Koreeda S; Miyachi Y; Kabashima K
    J Am Acad Dermatol; 2011 Jun; 64(6):1212-3. PubMed ID: 21571200
    [No Abstract]   [Full Text] [Related]  

  • 15. Complications of Long-Term Prostaglandin E1 Use in Newborns With Ductal-Dependent Critical Congenital Heart Disease.
    Alhussin W; Verklan MT
    J Perinat Neonatal Nurs; 2016; 30(1):73-9. PubMed ID: 26813395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal cortical hyperostosis. A side effect of prolonged prostaglandin E1 infusion].
    Fernández MA; Gebara E
    Arch Argent Pediatr; 2011 Apr; 109(2):154-9. PubMed ID: 21465075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing care of the neonate receiving prostaglandin E1 therapy.
    Rikard DH
    Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin-induced hyperostosis. A case report.
    Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
    Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The harlequin color change and association with prostaglandin E1.
    Rao J; Campbell ME; Krol A
    Pediatr Dermatol; 2004; 21(5):573-6. PubMed ID: 15461766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease.
    Aykanat A; Yavuz T; Özalkaya E; Topçuoğlu S; Ovalı F; Karatekin G
    Pediatr Cardiol; 2016 Jan; 37(1):131-4. PubMed ID: 26260095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.